Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Julphar
McKinsey
Covington
Boehringer Ingelheim
Argus Health
Merck
Mallinckrodt
Moodys
Daiichi Sankyo

Generated: January 19, 2018

DrugPatentWatch Database Preview

Pimecrolimus - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pimecrolimus and what is the scope of pimecrolimus patent protection?

Pimecrolimus
is the generic ingredient in one branded drug marketed by Valeant Bermuda and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for pimecrolimus. Two suppliers are listed for this compound.
Pharmacology for pimecrolimus

US Patents and Regulatory Information for pimecrolimus

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Bermuda ELIDEL pimecrolimus CREAM;TOPICAL 021302-001 Dec 13, 2001 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Valeant Bermuda ELIDEL pimecrolimus CREAM;TOPICAL 021302-001 Dec 13, 2001 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for pimecrolimus

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Bermuda ELIDEL pimecrolimus CREAM;TOPICAL 021302-001 Dec 13, 2001 ➤ Subscribe ➤ Subscribe
Valeant Bermuda ELIDEL pimecrolimus CREAM;TOPICAL 021302-001 Dec 13, 2001 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Citi
US Department of Justice
Dow
Cantor Fitzgerald
Colorcon
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot